comprehensive -WSS

comprehensive

author：entertainment 2025-09-06 09:41:17 Page View：157

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Colonoscopy at 40? Study finds a possible benefit
Next article： The high cost of giving birth even with insurance

knowledge

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

ASCO Daily Recap: CAR

AdobeYou’rereadingthewebeditionofASCOin30Seconds,STAT’sguidetotheAmericanSocietyofClinicalOncologyan

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Senators tussle over abortion against the backdrop of a presidential campaign

Sen.BillCassidy(R-La.),amemberofthechamber'shealthcommittee,saidduringthehearing:“It'spartisanpoliti

comprehensive

explore

knowledge

Senators tussle over abortion against the backdrop of a presidential campaign